Original Contribution
Mexiletine therapy in patients with chronic drug-resistant malignant ventricular arrhythmias
Clinical efficacy, safety, and side effects
Dale L. Haggman, D.O., James D. Maloney, M.D., Victor A. Morant, M.D., Lon W. Castle, M.D., Marilyn King-Rankine, M.D. and Marlene Goormastic, M.P.H.
Cleveland Clinic Journal of Medicine June 1986, 53 (2) 171-179;
Dale L. Haggman
Department of Cardiology, The Cleveland Clinic Foundation.
James D. Maloney
Department of Cardiology, The Cleveland Clinic Foundation.
Victor A. Morant
Department of Cardiology, The Cleveland Clinic Foundation.
Lon W. Castle
Department of Cardiology, The Cleveland Clinic Foundation.
Marilyn King-Rankine
Department of Cardiology, The Cleveland Clinic Foundation.
Marlene Goormastic
Department of Biostatistics and Epidemiology, The Cleveland Clinic Foundation.
In this issue
Cleveland Clinic Journal of Medicine
Vol. 53, Issue 2
20 Jun 1986
Mexiletine therapy in patients with chronic drug-resistant malignant ventricular arrhythmias
Dale L. Haggman, James D. Maloney, Victor A. Morant, Lon W. Castle, Marilyn King-Rankine, Marlene Goormastic
Cleveland Clinic Journal of Medicine Jun 1986, 53 (2) 171-179;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.